Meng Lv, Lin Wang, Wang Mingkun, Ting Zhao, Xu-Ying Pei, Xiao-Dong Mo, Yuqian Sun, Xiao-Hui Zhang, Na Kuang, Xiao-Jun Huang, Xiang-Yu Zhao. "First-in-human dual-epitope nanobody anti-CD5 CAR-T for relapsed/refractory T-ALL/PTCL: Phase I dose-escalation and expansion results from the CONQUER trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.6508